/ /

Laird Harrison
New world order of glaucoma presenting strong challenges
Changes in both technology and the healthcare policy are presenting new challenges for glaucoma specialists. As the demand for eye care surges, ophthalmologists are struggling to keep up–despite the availability of better tools for diagnosis and treatment.
Artificial intelligence will bring ‘reality’ to glaucoma diagnosis
Robert Chang, MD, outlines how artificial intelligence might work in glaucoma.
Preloaded IOLs ease surgical workflow
Preloaded IOL systems can save almost 30 seconds of operating time in cataract surgery, according to Damien Goldberg, MD, who participated in a trial with a preloaded delivery system (AcrySof IQ IOL Model AU00TO with UltraSert, Alcon Laboratories).
How to evaluate the guidelines of antibiotic reactions in surgery
Eye surgeons should use intracameral antibiotics only in select situations; they should avoid aminoglycosides, and they should not use vancomycin as prophylaxis. Michael Jumper, MD, offered this perspective as part of an overview of antibiotics used in intraocular surgery during the Glaucoma Symposium at the 2017 Glaucoma 360 meeting.
Questionnaires differ in strabismus quality-of-life measures
Two questionnaires used to measure quality of life in people with strabismus overlap but differ in important areas, according to researchers.
How adaptive optics will change retinal imaging
How adaptive optics will change retinal imaging
Adaptive optics could allow clinicians to monitor the progression of retinal diseases cell-by-cell, according to Jacque Duncan, MD.
First patients enrolled in dry eye device study
Patient recruitment has started in a randomised clinical trial testing an experimental device (Lamelleye, known also as CXB/1-14) for the treatment of dry eye disease (DED).
Ebola may leave retinal scar
The Ebola virus may leave a retinal scar specific to the disease, according to researchers. “The distribution of these retinal scars or lesions provides the first observational evidence that the virus enters the eye via the optic nerve to reach the retina in a similar way to West Nile virus,” said Dr Paul Steptoe of the Royal Liverpool Hospital, in a press release.
Glaucoma monitoring implant receives CE mark
An implantable glaucoma sensor has received CE mark approval for marketing in the European Union. The sensor (Eyemate, Implandata Ophthalmic Products) can provide frequent IOP readings, informing patients and their physicians about how the pressure changes by time of day and from one day to another.
NICE recommends dexamethasone adalimumab for uveitis
The UK’s National Institute for Health and Care Excellence (NICE) has given preliminary approval to dexamethasone 0.7 mg intravitreal implant (Ozurdex, Allergan) and adalimumab (Humira, AbbVie) for sight-threatening non-infectious posterior uveitis.